the context of specific autoantibodies to aid diagnosis. The paraneoplastic subtype has been recognised for some time, notably in the absence of antisynthetase autoantibodies. More frequently, malignancies such as breast, ovarian and lung cancers as well as Hodgkin's lymphoma are implicated, though we present a rare case of metastatic melanoma recurrence associated with the known phenotype. Case description: A 35-year-old lady of British origin presented to the acute medical take with a 4-week history of progressive, symmetrical proximal weakness predominantly affecting her neck, shoulders, deltoids and hip flexors. She had textbook Gottron's papules overlying her metacarpophalangealjointsaswell asaheliotrope rash,V-signandshawl sign consistent with dermatomyositis. Her past medical history comprised superficial spreading melanoma, excised from skin over her right scapula5yearspreviously with noevidence of metastaticdisease onsentineloraxillary nodebiopsies.Shealsohadwell-controlled ulcerativecolitis and eczema. She took no regular medications and there was no relevant family history of note. Initial biochemistry revealed a significantly elevated creatine kinase just north of 7000, a correspondingly raised alanine aminotransferase, but normal acute phase reactants. Interestingly, all autoimmune serology, including a dedicated myositis immunoblot, was negative. This finding, in addition to her past medical history, raised the suspicion of a paraneoplastic phenomenon. Indeed, FDG-PET/CT demonstrated an intensely avid splenic lesion (maximum standardized uptake value, max-SUV 10.7) concerning for metastasis. A faintly avid left apical lung nodule and lower density lesions within the liver were also visualised and further elucidated on ensuing cross-sectional staging imaging and a dedicated MRI of the liver. The FDG-PET/CT also highlighted moderate muscular uptake within the neck and upper limbs, whilst patchy high signal involving almost all muscle groups in both legs was seen on MRI in keeping with active inflammation. Subsequently, a right vastus lateralis muscle biopsy and an ultrasound-guided splenic biopsy were urgently performed without complication prior to initiation of intravenous methylprednisolone followed bya tapering course of oral prednisolone. Splenic histology revealed metastatic melanoma. After in-depth discussions with oncology the patient commenced encorafenib & binimetinib with marked symptomatic benefit. She continues to exhibit radiological and biochemical improvement to this day. Discussion:This is aninterestingand rare case. Ourreview of the existing literature found only 10 reports of melanoma presenting as paraneoplastic dermatomyositis. Melanoma is known to metastasise to the spleen, though it is extremely rare for it to be the first implicated site of spread. Rather, it is often a sign of multi-visceral involvement, and only found at post-mortem in the majority of cases. Evidently, therefore, stage IV malignant melanoma (distant metastases beyond regional lymph nodes) involving the spleen confers grave prognosis. This case demonstrates efficient use of the MDT leading to an accurate diagnosis and the swift initiation of effective treatment. Though it was initially felt the patient would require a splenectomy, the Oncologists and patient came to the shared decision that the use of BRAF and MEK inhibitors was preferable given the additional involved sites and the need to interrupt or delay dosing in the peri-operative period. Both agents selectively target key enzymes in the tumour-promoting MAPK pathway and initial signs are encouraging, with a repeat FDG-PET/CT a week into treatment demonstrating a significantly reduced metabolic activity in the spleen (SUV-max 3.5). The left apical lung nodule also appeared smaller onthe CT component and will continue tobe monitored. The muscle biopsy, largely academic in this context, should still garner interest. Perivascular lymphocytes were seen in both perimysium and endomysium leading to scattered atrophic fibres, though the perifascicular predilection that is highly characteristic of dermatomyositis was not observed in this case. However, immunohistochemistry in the paraffin sections demonstrated CD4 positive perivascular cells in the endomysium with no significant CD8 cells. This favourable ratio of CD4 is a hallmark of this subtype of idiopathic inflammatory myositis, in contrast with polymyositis where a CD8 infiltrate dominates. The lack of necrosis contrasts with another subtype, necrotising autoimmune myopathy. Key learning points: This case highlights a rare subtype of idiopathic inflammatory myositis with a characteristic phenotype. Negative autoantibodies should raise suspicion of paraneoplastic pathology and a comprehensive history and examination of the patient should be undertaken followed by appropriate diagnostic tests. It is important to note treatment of the underlying neoplasm led to a much greater degree of improvement in clinical symptoms, compared to conventional corticosteroid therapy. This is acommon theme described in the paraneoplasticsubtype. As aforementioned, it is rare for the spleen to be the first site of melanomatous metastatic spread. Splenic involvement is more commonly seen in the context of advanced disseminated disease which confers a poor prognosis. The estimated 5-year survival rate for stage IV disease is approximately 20%, though the use of novel targeted treatments and a relatively young age at diagnosis are just a couple of factors in this case that could lead to aconclusion that defies the odds. Obtaining histology in a swift manner is another key factor that can lead to improved outcomes, though the spleen has a rich vascular supply and thus biopsy carries a significant complication risk. Therefore, it should only be performedby highly experienced radiologistsor surgeons. The casealsoplaces emphasisontherole ofFDG-PET/CTas adiagnostic and prognostic tool. SUV-max figures aid interpretation but should always be compared with a physiological baseline as patient-related factors can vary. A SUV-max greater than 2.5 is generally indicative of malignancy though this level can also be seen in the context of infection or active inflammation so clinical correlation is always advised. Values in excess of 10,as inthis case, bear a high likelihood of aggressive disease. Conflict of interest: The authors declare no conflicts of interest.
ALL THAT GLITTERS IS NOT GOLD
Ashley Coope 1 , Sabrina Juman 2 , and Sanjeet Kamath 2 1 Rheumatology, University of Manchester, Manchester, United Kingdom, and 2 Rheumatology, Salford Royal Foundation Trust, Salford, United Kingdom Introduction: Inflammatory muscle disease is a rare but well-recognised manifestation of systemic vasculitis. It can present as focal myositis or symmetrical proximal muscle involvement seen in polymyositis and dermatomyositis. Investigative findings in inflammatory myositis include raised creatine kinase, abnormal electromyography and muscle biopsy. MR scans can identify muscle abnormality, oedema, fibrosis and the extent of muscle involvement, and are routinely requested to evaluate patients with suspected or definite myositis. They also guide us to the appropriate muscles to biopsy. MR scans are not diagnostic of myositis and treating clinicians must be aware of its mimics. Our case demonstrates one such mimic. Case description: A 59-year-old male patient under care of the renal physicians for ANCA-associated vasculitis complained of bilateral thigh pain. He had completed IV cyclophosphamide therapy (CYCLOPs protocol) for vasculitis affecting lungs, kidneys, and ENT. He was taking 30mg prednisolone and 100mg azathioprine daily. He denied muscle weakness, paraesthesia, or sensory symptoms. There was no muscle wasting, fasciculation,or sensory loss. Deep tendon reflexes were normal. 8-months prior, he was investigated for right hip pain and paraesthesia with MR spine and right hip, and neurophysiological studies. Investigations confirmed lumbar disc prolapse with neurophysiology in keeping with right L4 denervation changes. He had been treated with physiotherapyand daily pregabalin, duloxetine, and co-codamol. Renal physicians requested MR thigh, which was reported as muscle oedema over the long length of the right vastus medialis and lateralis, suggesting myositis. Rheumatology referral for myositis related to vasculitis was made. He was PR3þve-3IU/ml (improved), ESR-2, CRP-4.6mg/L, CK-94U/L. EGFR remained stable at 66ml/min. Clinical features were not supportiveof myositis and systemic vasculitis was in remission.The decision was made to discuss scans at the rheumatology-radiology meeting before consideringa change in immunosuppression or muscle biopsy. Radiologists felt that findings of localised muscle group involvement suggested a neurogenic cause rather than primary muscle inflammation. They had reviewed MR lumbar spine donepreviously whichhad identified degenerative changes with right foraminal stenosis at L3-4 and L4-5 disc space. Electrophysiology showed chronic neurogenic changes of moderate severity in predominately L4 innervated muscles -vastus medialis and adductor magnus of the right lower limb. Findings were supportive of chronic right L4 radiculopathy and not a vasculitic neuropathy or myositis. Hence immunosuppression was left unchanged. He responded well to physiotherapyand did not require spinal surgical intervention. Discussion: Our patient developed bilateral thigh pain in the setting of vasculitis. MR imaging was suggestive of myositis. Differential diagnoses included myositis related to vasculitis, primary focal myositis followed by vasculiticneuropathy, or denervation changes due to nerve entrapment. MRI is an excellent imaging modality for skeletal muscle due to its soft tissueresolution.It helps in narrowing differentials inskeletal muscle pathology, clinicians are able to identify individually affected muscle or muscle groups, give information about active muscle inflammation and/or damage. They can assist clinicians in targeting muscle for biopsy. Pattern and extent of muscle involvement can provide valuable clue to peripheral nerve orroot lesion. Though MR suggested myositis, clinical assessment was not typical of myositis. Our patient had no systemic features of active vasculitis, which are concurrently present in 80% of vasculitic neuropathies. Neurophysiology in vasculitic neuropathy typically shows evolving multifocal axonal neuropathy with reduced compound muscle action potential amplitudes. His electrophysiology was of chronic denervation in the L4 region and explained the patient's clinical symptoms and MR findings. For skeletal muscle pathology, three key patterns of MRI signal intensity include mass lesions, fatty infiltration and muscular oedema. In this patient, recognising unilateral muscle oedema localised to the vastus medialis and lateralis (innervated by L4) was key to diagnosis. Other muscles innervated by L4 nerve root are iliopsoas, tibialis anterior and posterior. Neurophysiology did demonstrate changes in iliopsoas muscle. In this patient, the muscle atrophy common to lower motor neurone lesions was not present. This is possible when partial denervation or reinnervation occurs, changes noted on neurophysiological studies in this patient. Our case shows MR evidence of myositis may not always equate to inflammatory myositis. In this patient, awareness of the radiological mimicsofmyositisavoidedamusclebiopsyorfurtherimmunosuppression. Key learning points: Myositis is an uncommon but recognised manifestation of systemic vasculitis. Chronic denervation can cause muscle abnormalities that appears similar to myositis on MR scan of the affected muscle. As such Clinicians need to be aware of this similarity and in patients with localised or focal myositis. Knowledge of the muscles innervations may help to establish a neurogenic aetiology where muscles are solely affected. Muscle atrophy can be notably absent in denervated muscle if the nerve is partially denervated orregenerating. Conflict of interest: The authors declare no conflicts of interest.
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